期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
血液系统/造血器官及免疫药物:04065 GPC/Debiopharm联合开发治疗免疫疾病的药物
1
作者 李燕燕 《国外药讯》 2005年第4期27-27,共1页
GPC生物技术公司和Debiopharm公司已结成联盟共同开发GPC公司针对自体免疫疾病领域的临床前小分子MHCⅡ类拮抗剂项目。
关键词 联合开发 治疗免疫疾病药物 GPC生物技术公司 Debiopharm公司
下载PDF
Comparative Alternative Medicinal (CAM) Properties in Camel Milk for Treatment of Epidemic Diseases 被引量:1
2
作者 Yagil Reuven 《Journal of Agricultural Science and Technology(A)》 2013年第8期575-580,共6页
This communication brings scientific evidence to explain the basis for efficacy of camel milk, especially on diseases where the immune system is compromised. Camels (Camelu sdromedarius) have very small and active a... This communication brings scientific evidence to explain the basis for efficacy of camel milk, especially on diseases where the immune system is compromised. Camels (Camelu sdromedarius) have very small and active antibodies, nanaobodies. Their special properties are being used by the USA Department of Homeland Security as bio-receptors to determine which substance could be used in a biological warfare attack. The antibodies are part of the "protective proteins" in camel milk. These include potent antibacterial, antiviral and antifungal properties. Camel milk antibodies are, in fact, "nanobodies". They are not destroyed in their passage through the stomach. These nanobodies are responsible for data concerning the use of camel milk in autoimmune diseases. Various diseases treated with camel milk are presented, as is the mode of action. The effect of pasteurization on activity of camel milk is presented as a way to overcome the need for heat. This is accomplished by presenting "pathogen-free" camel milk. The antibodies are part of the "protective proteins" in camel milk. These include potent antibacterial, antiviral and antifungal properties. The effect of pasteurization on activity of camel milk is presented as a way to overcome the need for heat. This is accomplished by presenting "pathogen-free" camel milk. 展开更多
关键词 Camel milk AUTOIMMUNE IMMUNOGLOBULINS protective proteins ANTIBODIES Crohn disease autism.
下载PDF
Development of artemisinin drugs in the treatment of autoimmune diseases 被引量:5
3
作者 Yanwei Wu Wei Tang Jianping Zuo 《Science Bulletin》 SCIE EI CAS CSCD 2016年第1期37-41,共5页
Artemisinin drugs are a family of sesquiterpene trioxane lactone agents originally derived from Artemisia annua L. Due to the big victory in the antimalarial battle,the 2015 Nobel Prize goes to the discoverer of artem... Artemisinin drugs are a family of sesquiterpene trioxane lactone agents originally derived from Artemisia annua L. Due to the big victory in the antimalarial battle,the 2015 Nobel Prize goes to the discoverer of artemisininbased therapy for malaria. Beyond antimalaria, artemisinin and its derivatives are also being investigated in diseases like schistosomiasis, viral infection, cancers and inflammation. Over the past decades, the anti-inflammatory and immunomodulatory effects of artemisinin drugs have been comprehensively studied. In this article, we will briefly describe the development of artemisinin drugs, especially novel artemisinin derivatives, in the treatment of autoimmune diseases. 展开更多
关键词 Artemisinin - Autoimmune disease Anti-inflammatory Immunosuppressive SM934
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部